ABT vs. ISRG, BSX, SYK, MDT, BDX, EW, IDXX, RMD, DXCM, and STE
Should you be buying Abbott Laboratories stock or one of its competitors? The main competitors of Abbott Laboratories include Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), and STERIS (STE). These companies are all part of the "health care equipment" industry.
Abbott Laboratories vs. Its Competitors
Abbott Laboratories (NYSE:ABT) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability, earnings and media sentiment.
In the previous week, Abbott Laboratories had 9 more articles in the media than Intuitive Surgical. MarketBeat recorded 60 mentions for Abbott Laboratories and 51 mentions for Intuitive Surgical. Intuitive Surgical's average media sentiment score of 1.52 beat Abbott Laboratories' score of 1.30 indicating that Intuitive Surgical is being referred to more favorably in the news media.
Abbott Laboratories has higher revenue and earnings than Intuitive Surgical. Abbott Laboratories is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
Abbott Laboratories has a beta of 0.73, indicating that its stock price is 27% less volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 1.67, indicating that its stock price is 67% more volatile than the S&P 500.
Abbott Laboratories has a net margin of 31.89% compared to Intuitive Surgical's net margin of 28.41%. Abbott Laboratories' return on equity of 19.01% beat Intuitive Surgical's return on equity.
Abbott Laboratories currently has a consensus target price of $142.61, suggesting a potential upside of 4.79%. Intuitive Surgical has a consensus target price of $588.95, suggesting a potential upside of 8.38%. Given Intuitive Surgical's higher probable upside, analysts clearly believe Intuitive Surgical is more favorable than Abbott Laboratories.
75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are owned by institutional investors. 0.5% of Abbott Laboratories shares are owned by company insiders. Comparatively, 0.7% of Intuitive Surgical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Summary
Intuitive Surgical beats Abbott Laboratories on 9 of the 17 factors compared between the two stocks.
Get Abbott Laboratories News Delivered to You Automatically
Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ABT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Abbott Laboratories Competitors List
Related Companies and Tools
This page (NYSE:ABT) was last updated on 7/1/2025 by MarketBeat.com Staff
